Healwell AI

AI Healthcare Will Battle Integration Risks But Recover Slightly

AnalystLowTarget

Not Invested

Consensus Narrative from 11 Analysts

Published

12 Aug 25

AnalystLowTarget's Fair Value

CA$2.50

48.4% undervalued

04 Sep

CA$1.29

-11.6%

-3.0%

-11.6%

-3.0%

You can edit this narrative until Aug 12 10:29 PM. Then, changes will post as Updates.

Author's Valuation

CA$2.5

48.4% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CA$2.5

48.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

26.11%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.97%

Calculation

CA$20.36m

Earnings '28

85.30x

PE Ratio '28

CA$1.74b

Market Cap '28

CA$1.74b

Market Cap '28

583.83m

No. shares '28

CA$2.97

Share Price '28

CA$2.97 Share Price '28

Discounted to 2025 @ 5.97% p.a.

CA$2.50

Fair Value '25